Arie Belldegrun (UKBIO19)
August 6, 2024 09:24 AM EDTUpdated 12:28 PM
Financing
Startups

Arie Bellde­grun and team un­veil $600M life sci­ences cred­it firm amid strug­gling biotech mar­ket

Kyle LaHucik

Biotech Correspondent

A new $600-plus mil­lion cred­it firm was un­veiled Tues­day morn­ing from Arie Bellde­grun and oth­er well-known life sci­ences names.

Rather than …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Lil­ly to buy non-opi­oid pain biotech SiteOne for up to $1B

Up­dat­ed: Pa­tient dies in Rock­et gene ther­a­py tri­al, which is put on clin­i­cal hold by FDA

RFK Jr. ends an­nu­al Covid vac­cine rec­om­men­da­tions for kids, preg­nant women

No­var­tis won bid­ding war for kid­ney drug as Reg­u­lus' top three ex­ecs ex­pect to make over $100M com­bined

Bio­gen taps City Ther­a­peu­tics in RNAi deal worth up to $1B

sponsored

From weeks to days: how Aizon In­tel­li­gent Agents trans­form phar­ma val­i­da­tion

A service from the Financial Times